DTIL — PRECISION BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1357874 ·
Last close
$8.76
Market Cap
$226.03M
52W High
$9.62
52W Low
$6.00
ADV30
552,576
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 10,838,000 | — | -9,075,000 | -18,441,000 | 143,891,000 | 99,370,000 | 67,790,000 |
| Dec 2025 | 34,204,000 | — | 12,508,000 | 20,133,000 | 154,416,000 | 110,823,000 | 62,168,000 |
| Sep 2025 | 13,000 | — | -20,667,000 | -21,772,000 | 93,510,000 | 44,870,000 | 76,876,000 |
| Jun 2025 | 18,000 | — | -21,877,000 | -23,520,000 | 108,928,000 | 62,242,000 | 74,874,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-65,843,000
Investing CF
$-634,000
Financing CF
$95,162,000
CapEx
$-797,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.13
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-528,188,000
Inventory
—
Receivables
$0
ST Investments
$4,762,000
EBIT TTM
$-45,187,000
Pretax Income TTM
$-46,609,000
Interest Exp TTM
$1,422,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,073,000
EBITDA
$-37,739,000
Free Cash Flow
$-21,668,250
Enterprise Value
$163,630,576
Total Cash
$101,184,000
Total Debt
$28,466,000
Shares Out
25,802,247
Trailing EPS
$-2.17
Book Value
$2.95
ROE
-70.9%
ROA
-18.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,264,000 | -52,148,000 | -45,724,000 | 154,416,000 | 62,168,000 | — | -65,843,000 |
| Dec 2024 | 68,696,000 | -26,162,000 | 7,167,000 | 136,388,000 | 79,995,000 | — | -58,445,000 |
| Dec 2023 | 48,727,000 | -43,736,000 | -61,319,000 | 159,781,000 | 140,920,000 | — | -84,114,000 |
| Dec 2022 | 25,098,000 | -62,308,000 | -111,637,000 | 238,169,000 | 177,736,000 | — | -45,753,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CGEN | COMPUGEN LTD | $226.06M | $2.39 | — |
| IVVD | Invivyd, Inc. | $230.80M | $0.78 | — |
| AVXL | ANAVEX LIFE SCIENCES CORP. | $231.68M | $2.50 | — |
| CLLS | Cellectis S.A. | $217.37M | $2.99 | — |
| CHRS | Coherus Oncology, Inc. | $237.54M | $1.54 | — |
News headlines (Yahoo Finance, 1h cache)
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-07-10 11:01 · Yahoo
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
2026-07-08 14:32 · Yahoo
Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
2026-06-29 11:01 · Yahoo
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,
2026-05-21 17:30 · Yahoo
Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts
2026-05-13 11:07 · Yahoo
Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 12:25 · Yahoo
AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?
2026-04-27 12:18 · Yahoo
Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?
2026-04-20 11:59 · Yahoo
Should You Buy Precision BioSciences (DTIL) After Golden Cross?
2026-04-14 13:55 · Yahoo
Precision BioSciences (DTIL) Surpasses Q4 Earnings and Revenue Estimates
2026-03-12 12:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.